本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Carisma Therapeutics

0.3199
-0.0001-0.03%
成交量:290.66万
成交额:94.94万
市值:1,336.80万
市盈率:-0.27
高:0.3591
开:0.3139
低:0.3000
收:0.3200
52周最高:1.27
52周最低:0.1417
股本:4,178.81万
流通股本:3,125.58万
量比:0.06
换手率:9.30%
股息:- -
股息率:- -
每股收益(TTM):-1.1834
每股收益(LYR):-1.4588
净资产收益率:-362.79%
总资产收益率:-85.68%
市净率:-0.29
市盈率(LYR):-0.22

数据加载中...

2024/03/13

超过5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/03/07

超过5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2024/02/14

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/02

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/01/26

超过5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2023/11/09

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/11/09

重要事件披露

Form 8-K - Current report
2023/09/01

重要事件披露

Form 8-K - Current report
2023/08/10

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/08/10

重要事件披露

Form 8-K - Current report
2023/06/09

重要事件披露

Form 8-K - Current report
2023/05/12

重要事件披露

Form 8-K - Current report
2023/05/12

重要事件披露

Form 8-K - Current report
2023/05/11

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/04/28

SEC问询函

Form CORRESP - Correspondence
2023/04/28

SEC问询函

Form CORRESP - Correspondence
2023/04/04

重要事件披露

Form 8-K/A - Current report: [Amend]
2023/04/04

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2023/03/22

超过5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2023/03/17

超过5%披露

Form SC 13D - General statement of acquisition of beneficial ownership